Improving glycemic, lipid, and blood pressure outcomes is the essence of diabetes care. Maintaining consistently positive results is an ongoing challenge for every healthcare professional. After years of clinical practice, Mayer Davidson, MD, has developed a series of algorithmic techniques that can increase positive results. Based on ADA's Standards of Care, this book offers detailed treatment algorithms that have been shown to be clinically effective in improving outcomes in people with diabetes.
Improving glycemic, lipid, and blood pressure outcomes is the essence of diabetes care. Maintaining consistently positive results is an ongoing challenge for every healthcare professional. After years of clinical practice, Mayer Davidson, MD, has developed a series of algorithmic techniques that can increase positive results. Based on ADA's Standards of Care, this book offers detailed treatment algorithms that have been shown to be clinically effective in improving outcomes in people with diabetes.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
About the Author Mayer Davidson, MD is a well-known and respected researcher and an expert in clinical endocrinology. He is a Professor of Medicine at the UCLA School of Medicine and a Principal Investigator at the Clinical Center for Research Excellence at the Charles Drew University of Medicine and Science (Los Angeles). He is very active in the ADA community and was Editor-in-Chief of Diabetes Care from 2002 to 2006 and President of the American Diabetes Association from 1997 to 1998.
Inhaltsangabe
Chapter 1. Laying the Groundwork (General Background Glycemia Lipids Renal Evaluation Hypertension Aspirin Smoking Cessation Rationale for Algorithms); Chapter 2. Evidence-Based Principles of Dietary Therapy; Chapter 3. Glycemia (Goals of Therapy Principles of Treatment Non-Insulin Drugs Metformin Sulfonylurea Agents and Glinides Thiazolidinediones; Incretins - Background Incretin Analogs (Exenatide) Dipeptidyl Peptidase Inhibitors (Sitagliptin) Alpha-Glucosidase Inhibitors Markedly Symptomatic Type 2 Diabetic Patients. Pramlintide Self Monitoring of Blood Glucose Insulin General Approach Bedtime Insulin / Daytime Oral Antidiabetes Drugs Multiple Injections Premixed Insulins Delayed Response to NPH Insulin Correction Doses Glycemia Algorithm)Chapter 4. Dyslipidemia (Goals of Therapy Principles of Treatment Adverse Events Medications Dyslipidemia Algorithm); Chapter 5. Hypertension Background (Aldosterone Receptor Antagonists Alpha-Adrenergic Receptor Atagonists Alpha-Adrenergic Receptor Agonists Angiotensin Converting Enzyme Inhibitors Angiotensin II Receptor Antagonists Beta-Adrenergic Receptor Antagonists Calcium Channel Antagonists Renin Inhibitors Thiazide and Loop Diuretics Vasodilators (Direct) Hypertension Algorithm)
